With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their h ....
Read MoreAdvance Scalability, Accessibility and Affordability of Autologous Cell Therapies As the cell therapy space bears witness to an increasing number of ....
Read MoreDDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their commitment to D ....
Read MoreDespite the exciting advancements and new investments into the field, the development of new RNAi therapeutics is plagued by difficulties with extra-h ....
Read MoreWelcome to the 3rd mRNA Analytical Development Summit USEmpowering Advanced Analytics for Exceptional mRNA Therapeutics and Vaccines As access to fas ....
Read MoreThe late-stage gene therapy pipeline is rapidly evolving, with 10+ approvals across the FDA and EMA in the past year and several more BLA filings and ....
Read MoreDriving Innovation in Discovery and Chemistry, Validating Clinical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads and Formats ....
Read MoreThe bacteriophage community is experiencing a period of renaissance of funding and clinical breakthroughs, with 2023 having been a pivotal year when t ....
Read MoreWith the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as ....
Read MoreGPCRs-targeted drug discovery continues to gain exponential momentum, with advances in screening tools, characterization of dynamic confirmations and ....
Read MoreAdvance More Personalized Therapies for Rare and Common Kidney DiseasesThe surge of clinical breakthroughs in SGLT2s, GLP-1s and ERAs for CKD, signifi ....
Read MoreDetermining MoA and Satisfying Regulatory Requirements In the dynamic cell therapy landscape, the challenge of potency assay development looms large, ....
Read MoreThe 4th Wet AMD and Diabetic Eye Disease Drug Development Summit is returning to Boston this March to unite 70+ industry-based retinal vascular expert ....
Read MoreFollowing the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of exp ....
Read MoreThe 8th CCP Summit is the longest-standing industry-focused and cross-modality meeting, delving into the scientific and strategic challenges that have ....
Read MoreFollowing the success of the 3rd Annual Psychedelic Therapeutics and Drug Development Conference in 2023, we're thrilled to be hosting the 4th Annual ....
Read MoreDespite the exciting advancements and investments accelerating the development of mRNA therapies, there is still limited regulatory guidance. Moreover ....
Read MoreEli Lilly's 'triple G' drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up t ....
Read MoreJoin as a member* during the promotion and we will waive the joiner's fee (up to $75 savings). Plus, you can choose one of the following wellness offe ....
Read MoreLyte is a simple yet unique Sky Lantern Experience like no other. With Sky Lantern Festivals across the United States you don't have to travel far. Co ....
Read MoreGrab your family, friends, neighbors, or co-workers, and come experience one of the most magical moments as you watch thousands of L ....
Read More